The role also leads and develops a diverse global research organization, fostering scientific excellence, talent growth, and disciplined execution to ensure that deep understanding of disease biology, cancer cell death mechanisms, and patient needs is effectively integrated with Astellas' ADC platforms and capabilities to deliver transformative therapies for cancer patients. Reporting to the Head, Cancer Biology, the Head, Innate Immunity & Cancer Cell Death Biology provides global scientific and strategic leadership to identify, prioritize, and translate disease and biological insights into differentiated ADC product concepts and research strategies.